Naoto T Ueno, Director of the University of Hawaii Cancer Center, shared a post on X:
“Dr Sara Hurvitz presenting Dr Joyce O’Shaughnessy slide set.
Unfortunately, Dr O’Shaughnessy could not fly due to the weather condition.
It is surprising to know 30% will not receive 2nd line regimen for HER2+ MBC. ”
More posts featuring Naoto T Ueno on OncoDaily.